About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 2NCT00006332

Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate

Hepatocellular carcinoma (HCC) is a deadly tumor for which the incidence is increasing in the United States, primarily due to prevalence of hepatitis C infection. An important aspect of the developmen...

Lead sponsor: National Center for Research Resources (NCRR)•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

National Center for Research Resources (NCRR)

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients with definite diagnosis of HCC based on a Dynamic MRI revealing a vascular mass in the liver and histologic confirmation of HCC.
•Patients who are not candidates for surgical resection, OLT or radiofrequency ablation.
•Patients with no prior treatment for HCC.
•Patients with extrahepatic spread and/or vascular invasion are permissible.

Related studies

RECRUITINGPhase 1

A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors

NCT06687941 · Neoplasms, Carcinoma, Hepatocellular, and more

RECRUITINGPhase 2

A Prospective Study to Evaluate the Safety and Efficacy of the Combination Therapy of Irpagratinib, Atezolizumab, and Bevacizumab in Patients With Hepatocellular Carcinoma

NCT07010497 · Carcinoma, Hepatocellular

Perioperative Risk of Immunotherapy Based Neoadjuvant and Conversion Therapy for Hepatocellular Carcinoma

NCT06571396 · Carcinoma, Hepatocellular, Immunotherapy

RECRUITINGPhase 2

Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative Resection

NCT06454578 · Carcinoma, Hepatocellular

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)

NCT05870969 · Carcinoma, Hepatocellular, Hepatitis C, Chronic, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 24, 2005Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment—

Start date—

Last updatedJun 24, 2005

Condition

Carcinoma, Hepatocellular

Locations shown

3912 Taubman Center

Ann Arbor, Michigan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 24, 2005Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions